Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$27,000.00

Exploring Synergistic Effects of Ketamine Infusions and Music in the Management of Chronic Noncancer Pain

FY 2024-25

Summary
IV ketamine is a specialised therapy for chronic pain patients unresponsive to conventional treatments. The mechanism of action is primarily by blocking special receptors that play an important role in pain processing, but the effects may not just be through pain relief; patients may report ‘dissociative’ effects, which is why ketamine is also considered an atypical psychedelic (‘mind-altering’) drug. It is thought that during IV ketamine, patients may also ‘reprocess’ their pain, similar to classic psychedelics. Recently, our group has shown that music (especially patient chosen music) may have pain-relief properties in acute and chronic pain models, through central effects on pain perception and interpretation. We propose to examine the effects of music in chronic pain patients undergoing IV ketamine infusion to evaluate if music choice affects the intensity and duration of pain relief by ketamine. We will recruit 35 patients at our clinic who already receive repeated IV ketamine for pain. The 1st infusion will be under normal conditions (‘baseline’). Patients will receive a music playlist through headphones during the proceeding infusions, consisting of either music of their choice (‘preferred’), music therapist choice, or silence in random order. They will record their pain scores during and between infusions (5-6 weeks) using widely accepted pain measurement tools. Thus, all patients will experience all 3 music conditions. We will also explore the subjective effects of the ketamine experience using interviews and qualitative analyses. We hypothesise that the preferred music will increase the intensity and duration of pain relief from IV ketamine compared to baseline. We expect to help optimise IV ketamine use at our clinic and others that offer this therapy.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
536583
Name
Suissa Raquel
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring Synergistic Effects of Ketamine Infusions and Music in the Management of Chronic Noncancer Pain
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chronic Pain; Complementary Therapy; Drug Therapy; Ketamine; Mixed Methods; Music; Neuroscience; Pain Management; Psychedelic; Randomized Controlled Trial
Abstract
IV ketamine is a specialised therapy for chronic pain patients unresponsive to conventional treatments. The mechanism of action is primarily by blocking special receptors that play an important role in pain processing, but the effects may not just be through pain relief; patients may report ‘dissociative’ effects, which is why ketamine is also considered an atypical psychedelic (‘mind-altering’) drug. It is thought that during IV ketamine, patients may also ‘reprocess’ their pain, similar to classic psychedelics. Recently, our group has shown that music (especially patient chosen music) may have pain-relief properties in acute and chronic pain models, through central effects on pain perception and interpretation. We propose to examine the effects of music in chronic pain patients undergoing IV ketamine infusion to evaluate if music choice affects the intensity and duration of pain relief by ketamine. We will recruit 35 patients at our clinic who already receive repeated IV ketamine for pain. The 1st infusion will be under normal conditions (‘baseline’). Patients will receive a music playlist through headphones during the proceeding infusions, consisting of either music of their choice (‘preferred’), music therapist choice, or silence in random order. They will record their pain scores during and between infusions (5-6 weeks) using widely accepted pain measurement tools. Thus, all patients will experience all 3 music conditions. We will also explore the subjective effects of the ketamine experience using interviews and qualitative analyses. We hypothesise that the preferred music will increase the intensity and duration of pain relief from IV ketamine compared to baseline. We expect to help optimise IV ketamine use at our clinic and others that offer this therapy.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Suissa, Raquel
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~